Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
MORE FILTERS
Positive or neutral estimate revisions for most companies. Best risk/reward over Q2 in Crayon, Link, NOD. Top picks: Atea, Crayon, Link, Pexip.
We are NOK 3m below cons . on Q2 EBITDA. Expect '24 margin guidance to be lifted to 15-18% (prev. 13-18%). BUY: 7-11% '24e-'26e FCF yields vs. peers at 3-4%.
We lift '25e-'26e EBIT by 20-24%. Less competition + less legacy dilution = growth to accelerate. BUY: 8-13% '24e-'26e FCF yields vs. peers at 2-6%.
Targets NOK 100-150m in EBITDA for 2023 Cost cuts not enough to take Pexip to good profitability Still a HOLD: Awaiting return to growth
ARR declined 5% q-o-q and was 3% below cons Adj. EBITDA in-line with cons, costs 9% lower Guides for NOK 100-150m in ‘23 EBITDA vs. cons 127m
Save your current filters as a new Interest
Would you like to receive real-time email alerts when a new report is published under this interest?
These search results will show up under 'Saved searches' in the left panel
Would you like to receive real-time email when a new report matches this search?
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.